Filter
5576
Filtered Results: 5576
Text search:
Centers
for
Disease
Control
and
Prevention
,
World
Health
Organization
Featured
Recommendations
589
New Publications
1514
Language
Document type
No document type
3098
Studies & Reports
894
Guidelines
782
Manuals
297
Strategic & Response Plan
227
Fact sheets
113
Training Material
67
Situation Updates
52
Resource Platforms
17
Infographics
10
Brochures
8
Online Courses
6
Dashboards/Maps
2
App
2
Videos
1
Countries / Regions
India
243
Global
236
Kenya
162
Sierra Leone
153
Liberia
144
Ethiopia
123
Nigeria
122
Western and Central Europe
118
Uganda
104
Africa
100
Latin America and the Carribbean
93
South Africa
89
Zambia
82
Nepal
76
Tanzania
76
Rwanda
73
Malawi
71
Ukraine
61
Ghana
59
Philippines
57
Bangladesh
57
Congo, Democratic Republic of
55
Syria
52
Myanmar / Burma
51
Eastern Europe
51
Guinea
50
Namibia
49
Russia
48
Mozambique
44
South Sudan
42
Middle East and North Africa
42
West and Central Africa
41
South–East Asia Region
41
Senegal
38
Zimbabwe
38
Cambodia
38
Asia
37
East and Southern Africa
34
Haiti
32
Lesotho
32
Brazil
31
Yemen
28
Burkina Faso
27
Germany
26
Indonesia
25
Eastern Europe and Central Asia
24
Botswana
20
Colombia
19
Madagascar
18
Venezuela
17
Pakistan
16
Eswatini/ Swaziland
16
Mali
15
Cameroon
15
Afghanistan
14
Thailand
14
Western Pacific Region
14
Somalia
13
Sudan
13
Central African Republic
12
Côte d’Ivoire / Ivory Coast
11
Angola
11
Paraguay
11
Benin
10
Albania
10
Moldova
10
Vietnam
10
Argentina
9
Laos
9
Tajikistan
9
Guinea-Bissau
8
Jordan
8
Lebanon
8
USA
7
Niger
7
Togo
7
Iraq
7
China
7
Georgia
7
Saudi Arabia
6
Peru
6
Chile
6
Chad
5
Gambia
5
North Macedonia
5
Burundi
5
Sri Lanka
5
Poland
5
Armenia
5
Timor Leste/ East Timor
5
North America
5
Turkey
4
Egypt
4
Hungary
4
Ecuador
4
Libya
4
Mexico
4
Palestine
4
Romania
4
Kazakhstan
4
Japan
4
Spain
4
Papua New Guinea
3
Honduras
3
El Salvador
3
Bolivia
3
Bhutan
3
Canada
3
Iran
3
Turkmenistan
3
Tunisia
3
Belarus
3
Morocco
2
Malaysia
2
Mauritania
2
Southern Africa
2
Congo-Brazzaville
2
Qatar
2
Bulgaria
2
Estonia
2
Slovakia
2
Uzbekistan
2
Kyrgyzstan
2
Gabon
2
Jamaica
2
France
2
Mauritius
2
Singapore
1
Serbia
1
Greece
1
Cape Verde
1
Other region
1
North Korea
1
Italy
1
Djibouti
1
Lithuania
1
Uruguay
1
Belgium
1
Maldives
1
United Kingdom
1
Morocco
1
Authors & Publishers
Publication Years
Category
Countries
2068
Clinical Guidelines
505
Public Health
375
Key Resources
248
Women & Child Health
229
Capacity Building
76
Pharmacy & Technologies
69
Annual Report MEDBOX
2
Protection & Security
1
Toolboxes
COVID-19
614
HIV
464
TB
392
Mental Health
313
Ebola
249
Rapid Response
239
AMR
208
NTDs
160
Planetary Health
153
NCDs
134
Caregiver
129
Conflict
113
Refugee
94
Disability
88
Global Health Education
83
Pharmacy
79
Zika
69
Cholera
48
Health Financing Toolbox
48
Natural Hazards
47
Polio
41
Specific Hazards
23
Social Ethics
7
South Sudan
2
Health Financing
2
Typhoon
1
To assess national-level responses to NCDs, WHO has implemented NCD country capacity surveys periodically since 2001. This report is the latest in that series. Since the first survey round, the NCD Country Capacity Survey (NCD CCS) has been conducted a further seven times, most recently in 2021. In ...
The "Global NCD action plan" provides a road map and a menu of policy options for countries to take in order to attain the 9 voluntary global targets, including that of a 25% relative reduction in p...
The Regional Action Framework for Noncommunicable Disease Prevention and ... provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination, sustainable financing, evidence-based policy, and community engagement, tailored to each Member State’s unique context. In doing so, Member States are encouraged to transform a disease treatment-centered “sick system” into a “health system” in which a population’s health and well-being enable socioeconomic development.
A Manual for Medical Officer
Developed under the Government of India – WHO Collaborative Programme 2008-2009
Accessed: 11.03.2019
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs are equivalent to 3.6% of gross domestic product. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment.
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Kyrgyzstan. This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs are equivalent to 3.9% of gross domestic product. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment.
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs (direct and indirect costs) comprise 2.3 trillion tenge, equivalent to 4.5% of gross domestic product in 2017. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment. For example, the salt policy package achieved a benefit-to-cost ratio of 118.4 over 15 years, a return of more than 118 tenge for every 1 tenge invested.
This report reviews the current situation in relation to national capacity to address NCDs and the progress made at country level over the past decade. It highlights that, while progress is being made, there is still much work to be done to create t...
This article summarises the process involved in developing the updated guideline and includes an infographic to highlight key IPC recommendations from the guideline, following the patient care pathway from the community to a healthcare facility to d...
This interim guidance is for LTCF managers and corresponding infection prevention and ... (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus from entering the facility and spreading within the facility, and 2) to support safe conditions for visiting through the rigorous application of IPC procedures for the residents’ well-being. WHO will update these recommendations as new information becomes available.
Availabel in English, French, Russian and Spanish
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-... sector (reduced workforce and productivity). In this study, it is estimated that NCDs cost Ethiopia at least 31.3 billion birr (US$ 1.1 billion) per year, equivalent to 1.8% of the gross domestic product (GDP). Less than 15% of the costs are for health care.
Health Evidence Network synthesis report 72
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS...
These guidelines provide recommendations for the non-pharmacological aspects of infection prevention and ... for acute respiratory diseases (ARD) in health care. Administrative and infection controls, including early detection, isolation and reporting, and establishment of infection control infrastructure, are key components for containment and mitigation of the impact of pathogens that may constitute a major public health threat. In these guidelines, the options of using natural ventilation and/or exhaust fan assisted ventilation in health-care facilities (HCF) are considered.
Cholera is a transmissible diarrhoeal infection caused by Vibrio cholerae. Endemic and/or epidemic in over 40 countries (mainly in Africa and Asia), cholera continues to be a major global public ... issue.
The World Health Organization (WHO) estimates that the number of cases reported worldwide represents in reality only 5 to 10% of actual cases.
This guide is intended for medical and non-medical staff responding to a cholera outbreak. It attempts to provide concrete answers to the questions and problems faced by staff, based on the recommendations of reference organisations, such as WHO and UNICEF, as well as Médecins Sans Frontières’ experience in the field.
It is divided into 8 chapters. Chapter 1, Cholera overview, outlines the epidemiological and clinical features of cholera. Chapter 2, Outbreak investigation, explains the method and stages of a field investigation, from the alert to implementation of initial activities. Chapter 3, Cholera control measures, details measures and tools to prevent and/or control cholera transmission and mortality in populations affected, or at risk of being affected, by an epidemic (curative care, prevention means and health promotion activities). Chapter 4, Strategies for epidemic response, addresses the roll-out strategies of the measures described in Chapter 3 which depend on context (e.g. urban, rural, endemic, non-endemic setting, etc.), resources and particular constraints. Chapter 5, Cholera case management, details the different stages of cholera treatment, from diagnosis through to cure.
Chapter 6, Setting up cholera treatment facilities, focuses on the installation of treatment facilities that vary in size and complexity according to operational requirements (treatment centres and units and oral rehydration points). Chapter 7, Organisation of cholera treatment facilities, describes the organisation of these specialized facilities in terms of human resources, supply, water, hygiene and sanitation, etc. Chapter 8, Monitoring and evaluation, presents the key data to be collected and analysed during an epidemic to facilitate a tailored response and evaluate its quality and effectiveness.
The guide includes various practical tools in the appendices to facilitate activities (e.g. water quality tests, job descriptions, documents, etc.). Moreover, the toolbox also contains additional tools in editable formats (individual patient file, cholera case register, pictograms).
Despite all efforts, it is possible that certain errors may have been overlooked in this guide. Please inform the authors of any errors detected.
To ensure that this guide continues to evolve while remaining adapted to field realities, please send any comments or suggestions.
The article outlines the prioritized research agenda for the prevention and control of chronic r...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a li...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
coun...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a li...
